ImmunoPrecise Antibodies Ltd. (IPA.V or IPATF)

Discussion in 'Penny Stocks' started by MarkITRight, Aug 19, 2020.

  1. MarkITRight

    MarkITRight Member

    Joined:
    May 23, 2018
    Messages:
    66
    Likes Received:
    24
    Taking a flyer on this.

    ImmunoPrecise Antibodies Ltd.
    IPA.V (TSX Venture)
    IPATF (OTC)

    Currently $1.53 (CAD)
    Right at the 50MA ($1.54) and 38.2 Fib retracement ($1.5).

    Antibody company that is still under the radar.
    400 customers globally.
    $12.5MM CAD in Revenue in in past 12 months (50% quarterly growth)
    They now work with 13/20 of the top pharmaceutical companies.
    Was granted $1.5MM from North Dakota grant and they are applying for federal US grant funding.

    Developing antibodies for Covid and also a rapid spit/saliva test to be used in public places.
    In negotiations with multiple pharma companies and recently hired a US PR Firm.

    I don't think it's gotten the attention in deserves for the work they're doing.

    84,500 shares bought by insiders the past 6 months.

    Fauci says there should be multiple vaccines and we clearly don't have a silver bullet yet.
    Lots of research is saying Covid is here to stay and it makes the case for testing kits and antibody testing for a longer period of time.

    https://www.zerohedge.com/markets/c...-more-infectious-original-discovered-malaysia

    Recently hired Crescendo Communications for US PR
    https://www.investorx.ca/doc/2008130516136617


    upload_2020-8-19_20-37-0.png

    Feel free to google Immunoprecise and the name of any of these if you want a quick confirmation.

    upload_2020-8-19_20-39-53.png


    Most recent Investor Presentation
    https://www.immunoprecise.com/wp-content/uploads/2020/07/ImmunoPrecise.July2020.pdf
     
  2. MarkITRight

    MarkITRight Member

    Joined:
    May 23, 2018
    Messages:
    66
    Likes Received:
    24
    Watch for the breakout


    upload_2020-8-26_22-32-24.png
     

    Attached Files:

  3. MarkITRight

    MarkITRight Member

    Joined:
    May 23, 2018
    Messages:
    66
    Likes Received:
    24
    Breakout confirmed, added more today.
    Earnings come out Monday and the quiet period will be over and their new IR firm can start earning their keep.

    Presenting on friday at the LD Micro conference.
    I honestly think they will do more investor conferences.
    https://ld500.ldmicro.com/
     
  4. MarkITRight

    MarkITRight Member

    Joined:
    May 23, 2018
    Messages:
    66
    Likes Received:
    24
    Released earnings over the weekend, solid numbers. Risks off the table (imo) and upside from IR team doing work, and the friday investor presentation.

    Cheers to all in the name, hasn't even moved much (up 2.86% to $1.8 CAD last I checked)

    iA Securities raised their price target from $2.10 to $2.50
    Full report

    upload_2020-8-31_12-31-21.png
     
  5. MarkITRight

    MarkITRight Member

    Joined:
    May 23, 2018
    Messages:
    66
    Likes Received:
    24
    Completed application to list on Nasdaq.


    Participating in the HC Wainwright conference early next week.

    Cheers to all the longs.

    Can’t post on here as much but it was a fun ride. IPA’s just getting started.
     
  6. MarkITRight

    MarkITRight Member

    Joined:
    May 23, 2018
    Messages:
    66
    Likes Received:
    24
    IPA.v breaking out on the way to $20

    50% revenue growth this past qtr
    $16.8 mill in cash

    Hoping for $30+ if you look at ABCL Nasdaq debut and their valuation you’ll see the value here.

    ABCL has $28mm usd in rev and 12.6B mkt cap

    IPA has $16.7 rev cad rev and 240mm mkt cap.

    Huge valuation gap which Nasdaq up listing should address

    Pt at iA raised from $16 to $20 price.

    Nasdaq Wed 12/30.

    New covid mutations and the vaccine mutations have been a great catalyst, but imagine the PR and news they’re holding for after the Nasdaq launch when institutional money can get involved.

    Cheers to all the longs.

    https://www.immunoprecise.com/immunoprecise-antibodies-to-begin-trading-on-nasdaq-stock-exchange/


    upload_2020-12-23_12-44-57.jpeg
     

    Attached Files:

  7. MarkITRight

    MarkITRight Member

    Joined:
    May 23, 2018
    Messages:
    66
    Likes Received:
    24
    Been a wild but amazing ride.
    Today is the day IPATF moves to the Nasdaq as ticker IPA!

    They are presenting at the JP Morgan health conference in January and should have pre-clinical results of their unique 4 mAbs polytope cocktail in 3-4 weeks.

    iA said (in past research notes) that they have more advanced lineup than ABCL, so $1+ Billion valuation is on the horizon if they execute properly. Currently valued at $281 million. Lots of potential. This is a play on covid vaccines not being the end all be all, but also they have many clients in their CRO business.

    Either way, watch this today to see how a Nasdaq move plays out.

    Cheers and good luck all!


    upload_2020-12-30_6-52-33.png
     

Share This Page